Smarter Site Feasibility Strategies for Predictable Enrollment in Late-Stage Oncology Trials, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how a patient pathway-focused approach can improve site selection in late-stage oncology trials. Attendees will gain insight into strategies to overcome challenges in oncology patient recruitment and retention. The featured speakers will discuss best practices for reducing site burden and strengthening site partnerships. The speakers will also share practical insights into how late-stage oncology trials can evolve to drive greater efficiency. 

TORONTO, Oct. 14, 2025 /PRNewswire/ -- Late-stage oncology trials face some of the most pressing challenges in drug development. Sites are often overwhelmed, patient eligibility requirements are increasingly complex and competition for both sites and participants continues to grow. Overcoming these hurdles demands innovative approaches that place the patient journey at the center of planning and execution.

This webinar will feature perspectives on rethinking site selection, feasibility and patient recruitment in ways that better align with the realities of modern oncology research. The featured speakers will explore how a paradigm shift in site selection methodology can open new opportunities for accessing the right patients, and how diagnostics, biomarkers and real-world considerations influence both recruitment and retention. In addition, the discussion will highlight strategies for reducing site burden and strengthening partnerships through training, streamlined processes and the integration of decentralized elements.

Through practical insights, attendees will gain a forward-looking perspective on how oncology trials can evolve to improve efficiency and patient outcomes in a highly competitive landscape.

Register for this webinar to learn how smarter site feasibility strategies can improve patient access and enrollment in oncology trials.

Join experts from Allucent, Sandra Olthof, MSc (Biomedical Science), Executive Director, Global Operations Head Oncology/Hematology; Almenia Garvey, Senior Director, Global Feasibility/Site Engagement; Alex Hartnagel, MSc (Health Science), Senior Director, Project Management; and Kitty Oudijk, MSc (Biomedical Engineering), Associate Director, Patient Engagement, for the live webinar on Wednesday, October 29, 2025, at 11am EDT (4pm CET/EU-Central).

For more information, or to register for this event, visit Smarter Site Feasibility Strategies for Predictable Enrollment in Late-Stage Oncology Trials.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit www.xtalks.com
For information about hosting a webinar visit www.xtalks.com/why-host-a-webinar/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]

SOURCE Xtalks